FEDERAL FUNDING

University Of California-San Diego gets $100K more for its Cancer Cause and Prevention Research grant

University Of California-San Diego

University Of California-San Diego received $100,000 from the Department of Health and Human Services under Cancer Cause and Prevention Research (93.393). USAspending records this action as "OTHER ACTION, FINANCIAL (modification 002)". Funds can be spent from December 1, 2022 to November 30, 2027.

This action
$100,000
Not the award total
Action date
Sep 8, 2026
65 days ago
Program
Cancer Cause and Prevention Research
Assistance listing 93.393
Spending window
1 year left
Ends November 30, 2027
$100.0K awardedSep 8

Reach the agencies that just got funded.

Get agency contacts free

Free account · 30-second setup · No credit card

Who to contact

People at University Of California-San Diego, the agency that received this funding.

Award details

Recipient
University Of California-San Diego
Awarding agency
Department of Health and Human Services
Sub-agency
National Institutes of Health
Awarding office
NIH National Cancer Institute
Assistance type
Grant
Action
OTHER ACTION, FINANCIAL (modification 002)
Period of performance
December 1, 2022 to November 30, 2027
Award ID (FAIN)
R01CA271104

About this award

From the award's filing with the federal government.

Evaluation of a telehealth oncofertility care intervention in adolescent and young adult cancer patients: a stepped wedge cluster randomized controlled trial - one of every 20 new cancer cases is diagnosed in an adolescent or young adult (aya) aged 12–39 years. Both female and male aya cancer patients experience increase risks of infertility and gonadal failure, devastating late effects which are preventable through effective fertility preservation (fp) services prior to cancer treatment. At the intersection of oncology and fertility, oncofertility care is the evidence-based practice of discussing reproductive risks with newly diagnosed cancer patients and supporting shared decision-making on fp services. Despite longstanding clinical guidelines, oncofertility care uptake is low because we currently lack scalable interventions to support its implementation in adult and pediatric cancer care settings. Drawing on implementation science, our transdisciplinary team conducted systematic environmental scans across 10 diverse health systems which corroborated prior research on barriers to care and led to the development, usability testing, pilot testing and tailoring of the multi-component telehealth oncofertility care (toc) intervention. Intervention components are: 1) ehr-based oncofertility needs screen and referral pathway to a virtual oncofertility hub; 2) telehealth oncofertility counseling through the hub; and 3) telehealth oncofertility financial navigation through the hub. The proposed toc trial is a stepped wedge cluster randomized trial of 18 adult and pediatric oncology clinics across three health systems. We will test the hypotheses that the intervention condition will be associated with increased proportion of patients who engage in goal-concordant oncofertility care (i.e., engagement in reproductive risk counseling and fertility preservation services that meet the patient’s fertility goals) (aim 1) and improved patient-reported outcomes and achievement of patient-centered goals (aim 2), compared to the usual care control condition. To decrease the time lag from research discovery to clinical care, we will evaluate intervention implementation using mixed methods guided by implementation science frameworks (aim 3). The toc intervention is innovative for its multi-level approach, medical financial hardship target, hub and spoke model bridging a virtual oncofertility hub with multi-institutional oncology clinics, and focus on contextual fit that enables implementation across separate ehr instances and in both adult and pediatric settings. The proposal is innovative in taking an implementation science-informed approach that considers policy, organizational context, and patient preference to evaluate effectiveness and implementation for future scale-up. Impact: responsive to congress’ childhood cancer survivorship, treatment, access and research (star) act of 2018 and nci’s nosis on use of telehealth in cancer-related care (not-ca-21-043) and addressing cancer-related financial hardship (not-ca-22-045), this proposal has the potential for high clinical impact through reducing significant inequities in access to oncofertility care and enabling aya cancer patients to engage in care that preserves their reproductive futures and improves life after cancer.

From USAspending

This record comes from USAspending.gov, the federal government's public database of spending. It describes one action on the award, so the amount shown is not the award's total.

View this award on USAspending(opens in a new tab)

Transaction 7529_R01CA271104_R01CA271104-91696886_93.393_002

Work in government? Get Civic IQ free →

Start finding government buyers today.
It's free.

B2G and SLED sales intelligence. Surface government procurement signals from 100,000+ state, local, and education agencies months before the RFP.

Get started free

No credit card required